|
MARK2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.246350E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.103600E-02 |
| Normal-vs-Stage2 |
1.980030E-01 |
| Normal-vs-Stage3 |
7.831900E-04 |
| Normal-vs-Stage4 |
1.480240E-02 |
| Stage1-vs-Stage2 |
9.143200E-01 |
| Stage1-vs-Stage3 |
1.312220E-02 |
| Stage1-vs-Stage4 |
2.253400E-01 |
| Stage2-vs-Stage3 |
1.504180E-01 |
| Stage2-vs-Stage4 |
4.838200E-01 |
| Stage3-vs-Stage4 |
3.994800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.837700E-03 |
| Normal-vs-AfricanAmerican |
4.218000E-01 |
| Normal-vs-Asian |
2.290200E-01 |
| Caucasian-vs-AfricanAmerican |
1.279790E-01 |
| Caucasian-vs-Asian |
3.152000E-02 |
| AfricanAmerican-vs-Asian |
1.321040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.156700E-04 |
| Normal-vs-Female |
5.555800E-01 |
| Male-vs-Female |
5.76129999999564E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.304300E-02 |
| Normal-vs-Age(41-60Yrs) |
5.722100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.242110E-02 |
| Normal-vs-Age(81-100Yrs) |
1.210160E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.577000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.257200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.915800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.500000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.074040E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.154600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.138180E-01 |
| Normal-vs-Grade 2 |
7.236000E-02 |
| Normal-vs-Grade 3 |
1.564180E-03 |
| Normal-vs-Grade 4 |
1.428330E-02 |
| Grade 1-vs-Grade 2 |
1.662160E-02 |
| Grade 1-vs-Grade 3 |
1.818800E-03 |
| Grade 1-vs-Grade 4 |
3.483800E-03 |
| Grade 2-vs-Grade 3 |
5.716300E-02 |
| Grade 2-vs-Grade 4 |
2.857600E-01 |
| Grade 3-vs-Grade 4 |
7.499400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.557800E-02 |
| Normal-vs-ccB subtype |
5.679600E-03 |
| ccA subtype-vs-ccB subtype |
1.318230E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.364500E-02 |
| Normal-vs-N1 |
7.122800E-01 |
| N0-vs-N1 |
4.218600E-01 |
|
|
